Environmental copper and manganese in the pathophysiology of neurologic diseases (Alzheimer's disease and manganism)

Acta Hydrochimica et Hydrobiologica

Volumn 33, Issue 1, 2005, Pages 72-78

  Dieter, Hermann H ^a   Bayer, Thomas A ^b   Multhaup, Gerd ^c  

^a UMWELTBUNDESAMT   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Amyloid precursor protein; Drinking water; Superoxide dismutase 1

Indexed keywords

COPPER; DISEASE PREVALENCE; DRINKING WATER; ENVIRONMENTAL FACTOR; MANGANESE; MEDICAL GEOGRAPHY;

EID: 20444488163     PISSN: 03234320     EISSN: None     Source Type: Journal    
DOI: 10.1002/aheh.200400556     Document Type: Article

References (56)

1. Bayer, T. A., Cappai, R., Masters, C. L., Beyreuther, K., Multhaup, G.: It all sticks together - the APP-related family of proteins and Alzheimer's disease. Mol. Psychiatry 4, 524-528 (1999).
2. Hesse, L., Beher, D., Masters, C. L., Multhaup, G.: The beta A4 amyloid precursor protein binding to copper. Febs Lett. 349, 109-116 (1994).
3. Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., Bush, A. I.: Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75, 1219-1233 (2000).
4. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Mastes, C. L., Beyreuther, K.: The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper(I). Science 271, 1406-1409 (1996).
5. Bush, A. I.: The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207-214 (2003).
6. Multhaup, G., Scheuermann, S., Schlicksupp, A., Simons, A., Strauss, M., Kemmling, A., Oehler, C., Cappai, R., Pipkom, R., Bayer, T. A.: Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease(1,2). Free Radic. Biol. Med. 33, 45-51 (2002).
7. White, A. R., Reyes, R., Mercer, J. F., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L., Cappai, R. : Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 842, 439-444 (1999).
8. Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. I., Li, Q. X.: Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670-44676 (2002).
9. Borchardt, T., Camakaris, J., Cappai, R., Masters, C. L., Beyreuther, K., Multhaup, G.: Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem. J. 344, 461-467 (1999).
10. Phinney, A. L., Drisaldi B., Lugowski, S., Schmidt, S. D., Coronado, V., Liang, Y., Horne, P., Yang, J., Sekoulidis, J., Coomaraswamy, J.: In vivo reduction of amyloid Aß by a mutant copper transporter. PNAS 100, 14193-14198 (2003).
11. Bayer, T. A., Schäfer, S., Simons, A., Kemmling, A., Kamer T., Tepest, R., Eckert, A., Schüssel, K., Eikenberg, O., Sturchler-Pierrat, C.: Dietary Cu stabilizes brain SOD-1 activity and reduces amyloid Aß production in APP23 transgenic mice. PNAS 100, 14187-14192 (2003).
12. Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., MacLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.: Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676 (2001).
13. Carlton, W. W.: Spongiform encephaiopathy induced in rats and guinea pigs by cuprizone. Exp. Mol. Pathol. 10, 274-287 (1969).
14. Sparks, D. L., Schreurs, B. G.: Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. PNAS 100, 11065-11069 (2003).
15. Bush, A. I., Masters, C. L., Tanzi, R.: Copper, ß-amyloid, and Alzheimer's disease: tapping a sensitive connection. PNAS 100, 11193-11194 (2003).
16. Squitti, R., Lupoi, D., Pasqualetti, P., Dal Forno, G., Vernieri, F., Chiovenda, P., Rossi, L., Cortesi, M., Cassetta, E., Rossini, P. M.: Elevation of serum copper levels in Alzheimer's disease. Neurology 59, 1153-1161 (2002).
17. Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G., Hsiao, K. K.: Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum. Mol. Genet. 6, 1951-1959 (1997).
18. Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., Carlson, G.: SOD-1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157-61 (1999).
19. McLoughlin, D. M., Standen, C. L., Lau, K. F., Ackerley, S., Bartnikas, T. P., Gitlin, J. D., Miller, C. C.: The neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity. J. Biol. Chem. 276, 9303-9307 (2001).
20. Bartnikas, T. B., Gitlin, J. D.: Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase. J. Biol. Chem. 278, 33602-33608 (2003).
21. Canavan, M. M., Cobb, S., Drinker, C.: Chronic manganese poisoning. Arch. Neurol. Psychiatry 32, 501-512 (1934).
22. Cook, D. G., Fahn, S., Brait, K. A.: Chronic manganese intoxication. Arch. Neurol. 30, 59-64 (1974).
23. Roels, H. A., Ortega Eslava, M. I., Ceulemans, E., Robert, A., Lison, D.: Prospective study on the reversibility of neurobehavioral effects in workers exposed to manganese dioxide. Neurotoxicology 20, 255-271 (1999).
24. Roels, H. A., Ghyselen, P., Buchet, J. P., Ceulemans, E., Lauwerys, R. R.: Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Brit. J. Industr. Med. 49, 25-34 (1992).
25. Mergler, D., Huel, G., Bowler, R., Iregren, A., Bélanger, S., Baldwin, M., Tardif, R., Smargiassi, A., Martin, L.: Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 64, 151-180 (1994).
26. Eriksson, H., Gillberg, P.-G., Aquilonius, S.-M., Hedström, K.-G., Heilbronn, E.: Receptor alternations in manganese intoxicated monkeys. Arch. Toxicol. 66, 359-364 (1992).
27. 2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol. Appl. Pharmacol. 115, 1-5 (1992).
28. Komura, J., Sakamoto, M.: Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: Long-term oral administration of several manganese compounds. Environ. Res. 57, 34-44 (1992).
29. Chen, J.-Y., Tsao, G. C., Zhao, Q., Zheng, W.: Differential cytotoxicity of Mn(II) and Mn(III): Special reference to mitochondrial [Fe-S] containing enzymes. Toxicol. Appl. Pharmacol. 175, 160-168 (2001).
30. Manganese Conference: Summary reports on sessions I-VIII. Neuro Toxicology 19, 452-489 (1998). Session II: Toxicokinetics and bioavailability of manganese, 475-478; Session III: Manganese and human health - Part I, 479-480; Session VI: Mechanisms of toxic action - Animal models, 483-485; Session VII: Related recent occupational studies of manganese, 486-487.
31. Korc, M.: Manganese. In: Prasad, A. S. (Ed.): Current Tropics in Nutrition and Disease, Vol. 18: Essential and Toxic Trace Elements in Human Health and Disease. Alan R. Liss Inc., New York, 1988, pp. 253-273.
32. Brown, D. R., Hafiz, F., Glassmith, L. L., Wong, B.-S., Jones, I. M., Clive, C., Haswell, S. J.: Consequences of manganese replacement of copper for prion protein function and proteinase resistance. The EMBO Journal 19, 1180-1186 (2000).
33. Florence, T. M., Stauber, J. L.: Manganese katalysis of dopamine oxidation. Sci. Total Environ. 78, 233-240 (1989).
34. Iwami, O., Watanabe, T., Moon, C. S., Nakatsuka, H., Ikeda, M.: Motor neuron disease on the Kii Peninsula of Japan: Excess manganese intake from food coupled with low magnesium in drinking water as a risk factor. Sci. Total Environ. 149, 121-135 (1994).
35. Yoshida, S., Yase, Y., Iwata, S., Mizumoto, Y., Chen, K.M., Gajdusek, D. C.: Comparative trace-elemental study on amyotrophic lateral sclerosis (ALS) and Parkinsonism-dementia (PD) in the Kii Peninsula of Japan and Guam. Wakayama Med. Rep. 30, 41-53 (1998).
36. Purdey, M.: Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Medical Hypotheses 54, 278-306 (2000).
37. Gianutsos, G., Morrow, G. R., Morris, J. B.: Accumulations of manganese in rat brain, following intranasal administration. Fundam. Appl. Toxicol. 37, 102-105 (1997).
38. 2) on the absorption and cerebral distribution of manganese in rats. Arch. Toxicol. 71, 223-230 (1997).
39. 2) to the rat brain: Toxi-cokinetic investigations in a unilateral nasal occlusion model. Toxicol. Appl. Pharmacol. 169, 238-248 (2000).
40. Tjälve, H., Henriksson, J., Tallkvist, J., Larsson, B. S., Lindquist, N. G.: Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol. Toxicol. 79, 347-356 (1996).
41. Vitarella, D., Wong, B. A., Moss, O. R., Dorman, D. C.: Pharmacokinetics of inhaled manganese phosphate in male sprague-dawley rats following subacute (14-day) exposure. Toxicol. Appl. Pharmacol. 163, 279-285 (2000).
42. Bench, G., Carlsen, T. M., Grant, P. G., Wollett, J. S. Jr., Martinelli, R. E., Lewis, J. L., Divine, K. K.: Olfactory bulb uptake and determination of biotransfer factors in the California ground squirrel (Spermophilus beecheyi) exposed to manganese and cadmium in environmental habitats. Environ. Sci. Technol. 35, 270-277 (2001).
43. Dorman, D. C., Brenneman, K. A., McElveen, A., Lynch, S. E., Roberts, K., Wong, B.: Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rat brain. J. Toxicol. Eviron. Health 65, 1493-1511 (2002).
44. Henriksson, J., Tjälve, H.: Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol. Sci. 55, 392-398 (2000).
45. Rao, D. B., Wong, B. A., McManus, B. E., McElveen, A. M., James, A. R., Dorman C.: Inhaled iron, unlike manganese, is not transported to the rat brain via the olfactory pathway. Toxicol. Appl. Pharmacol. 193, 116-126 (2003).
46. Ingersoll, R. T., Montgomery, E. B. Jr., Aposhian, H. V.: Central nervous system toxicity of manganese. I. Inhibition of spontaneous motor activity in rats after intrathecal administration of manganese chloride. Fundam. Appl. Toxicol. 27, 106-113 (1995).
47. Zheng, W., Perry, D. F., Nelson, D. L., Aposhian, H. V.: Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J. 5, 2188-2193 (1991).
48. Hauser, R. A., Zesiewicz, T. A., Rosemurgy, A. S., Martinez, C., Olanow, C. W.: Manganese intoxication and chronic liver failure. Ann. Neurol. 36, 871-875 (1994).
49. Pomier-Layrargues, G., Spahr, L., Butterworth, R. F.: Increased manganese concentrations in pallidurn of cirrhotic patients. Lancet 345, 735 (1995).
50. Wang, J. D., Chuang, C. C., Hwang, Y. H., Chiang, J. R., Lin, J. M., Chen, J. S.: Manganese induced Parkinsonism: an outbreak due to unrepaired ventilation control system in a ferromanganese smelter, Brit. J. Industr. Med. 46, 856-859 (1989).
51. Loranger, S., Zayed, J.: Environmental and occupational exposure to manganese: a multimedia assessment. Int. Arch. Occup. Environ. Health 67, 101-110 (1995).
52. Kondakis, X. G., Makris, M., Leotsinidis, M., Prinou, M., Papapetropoulos, T.: Possible health effects of high manganese concentration in drinking water. Arch. Environ. Health 44, 175-178 (1989).
53. Peng, H., Dehua, L., Gongqiao, Z.: Effects of high-level sewage irrigation on children's neurobehaviour. Chin. J. Prev. Med. 28, 216-218 (1995).
54. Gongqiao, Z., Dehua, L., Peng, H.: Effects of manganese on learning abilities in school children. Chin. J. Prev. Med. 29, 156-158 (1995).
55. Woolf, A., Wright, R., Amarasiriwardena, C., Bellinger, D.: A child with chronic manganese exposure from drinking water. Environ. Health Perspect. 110, 1-4 (2002).
56. Korf, G. P.: Langzeitgenuss von brunnengefördertem Trinkwasser unterschiedlichen Mangangehalts und neurologische Störungen. Eine umweltmedizinische Querschnittstudie. (Neurologic disturbances and the long-term ingestion of drinking water from private wells with different Mn levels. A cross-sectional environmental health study) Dissertation, Universität Lübeck, 1994.